Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Perth scientists embark on stroke therapy approach
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Sleep loss as risk factor for neurologic disorders: A review.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Expectations of multiple sclerosis patients and their families: a qualitative study in iran.
Drug expenditure of high-cost patients and their characteristics in Finland.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
So many progenitors, so little myelin.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Second generation S1P pathway modulators: Research strategies and clinical developments.
Multiple sclerosis in Syria.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
Syringomyelia coexisting with guillain-barre syndrome.
Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
Reliability and Validity of Ratings of Perceived Exertion in Persons with Multiple Sclerosis.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Childhood transverse myelitis and its mimics.
Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.
EDSS variability before randomization may limit treatment discovery in primary progressive MS.
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.

Pages